# OPRD1

## Overview
The OPRD1 gene encodes the delta-opioid receptor (DOP), a member of the G protein-coupled receptor (GPCR) family, which plays a crucial role in modulating pain, mood, and various metabolic processes. The receptor is characterized by its seven transmembrane domains, a hallmark of GPCRs, and is involved in the regulation of neurotransmitter release, contributing to analgesic effects and mood regulation (Granier2012Structure; Gendron2016Molecular). DOP is expressed in several tissues, including the central nervous system and pancreatic islets, where it influences insulin secretion and energy balance (Meulebrouck2024Functional). The receptor's activity is modulated by endogenous opioids, and it is implicated in reward pathways and the development of tolerance and dependence associated with opioid use (Zhang2010Functional). Variations in the OPRD1 gene have been linked to substance dependence, mood disorders, and other clinical conditions, underscoring its significance in both physiological and pathological contexts (Crist2013An; Filliol2000Mice).

## Structure
The OPRD1 gene encodes the delta-opioid receptor (DOP), a G protein-coupled receptor (GPCR) involved in pain modulation and mood regulation. The primary structure of the DOP consists of 372 amino acids, featuring seven transmembrane domains typical of GPCRs (Gendron2016Molecular). The secondary structure includes alpha-helices that span the cell membrane, forming a typical GPCR architecture (Gendron2019Molecular). 

The tertiary structure of the DOP involves the arrangement of these helices in a transmembrane domain, with a conserved β-strand fold in the extracellular loop 2 (ECL2) and a flexible ECL3 (Gendron2019Molecular). A significant feature is the sodium-dependent allosteric regulation site, where sodium ions stabilize the inactive conformation of the receptor (Gendron2019Molecular). 

Post-translational modifications such as palmitoylation, N-glycosylation, and O-glycosylation are crucial for the receptor's proper folding, membrane expression, and stability (Gendron2019Molecular). The receptor also contains conserved motifs like DRY, CWxP, and NP(x)2Y(x)6F, which are important for receptor activation and G protein coupling (Gendron2016Molecular). The quaternary structure may involve dimerization, as DOP can form homo-oligomers and hetero-oligomers with other opioid receptors (Gendron2016Molecular).

## Function
The OPRD1 gene encodes the delta opioid receptor (DOP), a G-protein-coupled receptor involved in various physiological processes. In healthy human cells, DOP plays a significant role in metabolic homeostasis and insulin secretion. It is highly expressed in human pancreatic islets, particularly in beta cells, where it regulates insulin secretion. The receptor's activity can influence plasma glucose concentrations and potentially affect the risk of type 2 diabetes by modulating insulin release (Meulebrouck2024Functional).

DOP is also involved in the thermogenic program in brown adipose tissue, impacting weight gain and food intake. This suggests a role in energy balance and adiposity regulation (Meulebrouck2024Functional). In the central nervous system, DOP modulates neurotransmitter release, contributing to pain perception and mood regulation (Granier2012Structure).

The receptor's function is modulated by endogenous opioids, which can lead to analgesic effects and influence mood. DOP's activity in the brain is linked to reward, tolerance, and dependence mechanisms associated with opioid use (Zhang2010Functional). These diverse roles highlight the receptor's importance in both metabolic and neurological processes.

## Clinical Significance
Mutations and variations in the OPRD1 gene, which encodes the delta-opioid receptor, have been associated with several clinical conditions, particularly in the context of substance dependence and mood disorders. Variants within the OPRD1 gene, such as rs678849, have been linked to differential treatment outcomes in opioid dependence among African-American patients. Those with the CC genotype of rs678849 show worse outcomes when treated with methadone and increased illicit opioid use when treated with buprenorphine (Crist2013An). In the Han Chinese population, the exonic SNP rs2234918 is associated with an increased risk of heroin dependence, suggesting a genetic predisposition linked to this variant (Huang2019OPRD1).

The OPRD1 gene is also implicated in mood regulation. Studies using Oprd1-deficient mice have shown increased anxiety and depressive-like behaviors, indicating the gene's role in modulating emotional responses (Filliol2000Mice). Additionally, the rs1042114 variant affects receptor maturation and has been associated with Alzheimer's disease, suggesting a broader impact on neurological conditions (Crist2016OPRD1). These findings highlight the clinical significance of OPRD1 in understanding and potentially treating addiction, mood disorders, and neurodegenerative diseases.

## Interactions
The delta-opioid receptor (DOPr), encoded by the OPRD1 gene, engages in various protein interactions that influence its function and trafficking. DOPr interacts with several proteins involved in intracellular trafficking, such as the coatomer protein complex I (COPI), which regulates its retention within the Golgi and endoplasmic reticulum (ER) through specific di-lysine and di-arginine motifs in its intracellular loops (StLouis2017Involvement). These interactions are crucial for controlling the receptor's cell-surface expression and intracellular localization (StLouis2017Involvement).

DOPr also interacts with Rab10, a protein that regulates its cell surface delivery and trafficking. Rab10 binds to the intracellular domains of DOPr, particularly the third intracellular loop and C-terminal tail, and is involved in its colocalization in Golgi-associated structures (Degrandmaison2020In). The interaction with Rab10 is significant for DOPr's trafficking and surface expression, impacting its physiological functions (Degrandmaison2020In).

Additionally, DOPr forms potential heteromeric complexes with other G-protein-coupled receptors (GPCRs), such as the mu-opioid receptor (MOPr), kappa-opioid receptor (KOPr), and cannabinoid receptor 1 (CB1), which may influence its signaling pathways (Degrandmaison2020In). These interactions suggest a complex network of regulatory mechanisms that modulate DOPr's function and pharmacological responses.


## References


[1. (Crist2016OPRD1) Richard C. Crist and Toni-Kim Clarke. OPRD1 Genetic Variation and Human Disease, pages 131–145. Springer International Publishing, 2016. URL: http://dx.doi.org/10.1007/164_2016_112, doi:10.1007/164_2016_112. This article has 10 citations.](https://doi.org/10.1007/164_2016_112)

[2. (Zhang2010Functional) Huiping Zhang, Joel Gelernter, Jeffrey R Gruen, Henry R Kranzler, Aryeh I Herman, and Arthur A Simen. Functional impact of a single-nucleotide polymorphism in the oprd1 promoter region. Journal of Human Genetics, 55(5):278–284, March 2010. URL: http://dx.doi.org/10.1038/jhg.2010.22, doi:10.1038/jhg.2010.22. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/jhg.2010.22)

[3. (Filliol2000Mice) Dominique Filliol, Sandy Ghozland, Johanna Chluba, Miguel Martin, Hans W.D. Matthes, Frédéric Simonin, Katia Befort, Claire Gavériaux-Ruff, Andrée Dierich, Marianne LeMeur, Olga Valverde, Rafael Maldonado, and Brigitte L. Kieffer. Mice deficient for δ- and μ-opioid receptors exhibit opposing alterations of emotional responses. Nature Genetics, 25(2):195–200, June 2000. URL: http://dx.doi.org/10.1038/76061, doi:10.1038/76061. This article has 552 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/76061)

[4. (Crist2013An) Richard C Crist, Toni-Kim Clarke, Alfonso Ang, Lisa M Ambrose-Lanci, Falk W Lohoff, Andrew J Saxon, Walter Ling, Maureen P Hillhouse, R Douglas Bruce, George Woody, and Wade H Berrettini. An intronic variant in oprd1 predicts treatment outcome for opioid dependence in african-americans. Neuropsychopharmacology, 38(10):2003–2010, April 2013. URL: http://dx.doi.org/10.1038/npp.2013.99, doi:10.1038/npp.2013.99. This article has 68 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/npp.2013.99)

[5. (Gendron2019Molecular) Louis Gendron, Karim Nagi, Manel Zeghal, Patrick M. Giguère, and Graciela Pineyro. Molecular aspects of delta opioid receptors, pages 49–90. Elsevier, 2019. URL: http://dx.doi.org/10.1016/bs.vh.2019.06.001, doi:10.1016/bs.vh.2019.06.001. This article has 8 citations.](https://doi.org/10.1016/bs.vh.2019.06.001)

[6. (Degrandmaison2020In) Jade Degrandmaison, Khaled Abdallah, Véronique Blais, Samuel Génier, Marie-Pier Lalumière, Francis Bergeron, Catherine M. Cahill, Jim Boulter, Christine L. Lavoie, Jean-Luc Parent, and Louis Gendron. In vivo mapping of a gpcr interactome using knockin mice. Proceedings of the National Academy of Sciences, 117(23):13105–13116, May 2020. URL: http://dx.doi.org/10.1073/pnas.1917906117, doi:10.1073/pnas.1917906117. This article has 21 citations.](https://doi.org/10.1073/pnas.1917906117)

[7. (Meulebrouck2024Functional) Sarah Meulebrouck, Judith Merrheim, Gurvan Queniat, Cyril Bourouh, Mehdi Derhourhi, Mathilde Boissel, Xiaoyan Yi, Alaa Badreddine, Raphaël Boutry, Audrey Leloire, Bénédicte Toussaint, Souhila Amanzougarene, Emmanuel Vaillant, Emmanuelle Durand, Hélène Loiselle, Marlène Huyvaert, Aurélie Dechaume, Victoria Scherrer, Piero Marchetti, Beverley Balkau, Guillaume Charpentier, Sylvia Franc, Michel Marre, Ronan Roussel, Raphaël Scharfmann, Miriam Cnop, Mickaël Canouil, Morgane Baron, Philippe Froguel, and Amélie Bonnefond. Functional genetics reveals the contribution of delta opioid receptor to type 2 diabetes and beta-cell function. Nature Communications, August 2024. URL: http://dx.doi.org/10.1038/s41467-024-51004-6, doi:10.1038/s41467-024-51004-6. This article has 0 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-024-51004-6)

[8. (StLouis2017Involvement) Étienne St-Louis, Jade Degrandmaison, Sébastien Grastilleur, Samuel Génier, Véronique Blais, Christine Lavoie, Jean-Luc Parent, and Louis Gendron. Involvement of the coatomer protein complex i in the intracellular traffic of the delta opioid receptor. Molecular and Cellular Neuroscience, 79:53–63, March 2017. URL: http://dx.doi.org/10.1016/j.mcn.2016.12.005, doi:10.1016/j.mcn.2016.12.005. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.mcn.2016.12.005)

[9. (Gendron2016Molecular) Louis Gendron, Catherine M. Cahill, Mark von Zastrow, Peter W. Schiller, and Graciela Pineyro. Molecular pharmacology ofδ-opioid receptors. Pharmacological Reviews, 68(3):631–700, June 2016. URL: http://dx.doi.org/10.1124/pr.114.008979, doi:10.1124/pr.114.008979. This article has 99 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1124/pr.114.008979)

[10. (Huang2019OPRD1) Chang-Chih Huang, Shin-Chang Kuo, Ta-Chuan Yeh, Yi-Wei Yeh, Chun-Yen Chen, Chih-Sung Liang, Chang-Chih Tsou, Chun-Long Lin, Pei-Shen Ho, and San-Yuan Huang. Oprd1 gene affects disease vulnerability and environmental stress in patients with heroin dependence in han chinese. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 89:109–116, March 2019. URL: http://dx.doi.org/10.1016/j.pnpbp.2018.08.028, doi:10.1016/j.pnpbp.2018.08.028. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.pnpbp.2018.08.028)

[11. (Granier2012Structure) Sébastien Granier, Aashish Manglik, Andrew C. Kruse, Tong Sun Kobilka, Foon Sun Thian, William I. Weis, and Brian K. Kobilka. Structure of the δ-opioid receptor bound to naltrindole. Nature, 485(7398):400–404, May 2012. URL: http://dx.doi.org/10.1038/nature11111, doi:10.1038/nature11111. This article has 567 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nature11111)